• Skip to main content
  • Skip to primary sidebar

An Inconvenient Truth: This Is a Woman

Don’t Get Angry, Get Active!

Hide Search

Johnson & Johnson’s Pre-Emption Defense Over Safety of Birth Control Patch

H. Sandra Chevalier-Batik · April 10, 2008 ·

IN THE COURTS: New York Times Examines Johnson & Johnson’s Pre-Emption Defense Over Safety of Birth Control Patch

From DAILY WOMEN’S HEALTH POLICY REPORT, [April 8, 2008]

The New York Times on Sunday examined Johnson & Johnson’s use of the legal doctrine of preemption to defend against claims that the birth control patch Ortho Evra causes blood clots or other adverse effects. Under this legal argument, if a product’s safety has been approved through a federal regulatory agency such as FDA, then its safety cannot be questioned in individual lawsuits. According to the Times, J&J is arguing that the company should be exempt from lawsuits because FDA approved the drug and its label in 2001 and its decisions should not be second guessed by the courts.

Lawyers for plaintiffs and pharmaceutical companies said that courts have dismissed the preemption argument for decades, but the strategy might be “on the verge of success,” the Times reports. The U.S. Supreme Court in February ruled that suits against makers of medical devices like pacemakers are preempted. The court is scheduled to rule on another case that could make pre-emption a legal standard for drug cases, the Times reports. The Bush administration has argued in favor of pre-emption.

According to the Times, Ortho Evra’s old label inaccurately described the amount of estrogen the patch released, and more than 3,000 women and their families have sued J&J, arguing that users of the patch suffered heart attacks, strokes and death in 40 cases. A J&J clinical trial of Ortho Evra completed in 1999 originally showed that the patch delivered “far more” estrogen daily than low-dose birth control pills, but the study’s author applied a “correction factor” that claimed the patch delivered 40% less estrogen than the trial showed, the Times reports. The correction factor was not in the study protocol submitted to FDA. However, Bob Tucker, an attorney representing J&J, said the agency was aware of the adjustment. Two other studies, one completed in 1999 and one in 2003, confirmed that the patch releases more estrogen than low-dose pills. FDA changed Ortho Evra’s warning label in November 2005, and an epidemiological study has since shown that women using the patch can have up to double the risk of developing blood clots as women taking the pill.

Gloria Vanderham, a J&J spokesperson, said the company acted responsibly. “We have regularly disclosed data to the FDA, the medical community and the public in a timely manner,” Vanderham said, adding, “Ortho Evra is a safe and effective birth control option for women when used according to the labeling.” Janet Abaray, an attorney representing a plaintiff suing the company, said J&J took advantage of FDA, which was overwhelmed by its responsibilities. The company “knew that FDA does not have the funding or the manpower to police drug companies,” Abaray said. FDA Commissioner Andrew von Eschenbach acknowledged that the agency faces a crisis and might not be “adequate to regulate the food and drugs of the 21st century” (Harris/Berenson, New York Times, 4/6).

Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women’s Health Policy Report, search the archives, or sign up for email delivery here.The Daily Woman’s Health Policy Report is a free service of the National Partnership for Women’s Health & Families, published by The Advisory Board Company.

Share

Filed Under: Big Pharma Watch Tagged With: Big Pharma Watch, Birth Control

Primary Sidebar

Categories

  • Attention-Deficit/Hyperactivity Disorder Medications
  • Big Pharma Watch
  • Biotech Industry
  • Birth Control
  • Breast Cancer
  • cáncer de cuello uterino
  • Cancer Research
  • Cervarix
  • Cervical Cancer
  • Clinical Trials
  • Diabetes
  • Domestic Violence
  • Drug Approvals
  • Emotional Health
  • FDA
  • FDA Black Box Warning
  • FDA Clinical Trials
  • FDA Failure To Protect
  • FDA Product Recall
  • Follow The Money
  • Gardasil
  • Gardasil®
  • Gender Bias
  • Gender Politics
  • genital warts
  • Guillain-Barre Syndrome
  • Hormone Cycle
  • HPV Infection
  • HPV Vaccine
  • HRT
  • HRT Side Effects
  • Influenza A Virus H1N1 Strain
  • Mammograms
  • Mandatory HPV Vaccination Policies
  • Medical Technology
  • Menopause
  • MERCK Watch
  • MMR vaccine
  • National Vaccine Injury Compensation Program
  • PAP Test
  • Prescription Drug Side Effects
  • Proactive Nutrition
  • Product Recall
  • Reproductive Health
  • Sexual Dysfunction
  • Sleep Loss
  • STD Infection
  • Stroke
  • Take Action!
  • Uncategorized
  • Unwanted Pregnancy
  • Vaccination Policy
  • VAERS
  • vaginal yeast infection
  • Virginity
  • Weight Gain
  • Women's Health
  • Women's Rights
  • Work Place Issues
  • World Health Organization
  • Yeast Infection
  • Your Body/Your Self

Archives

  • February 2010
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • March 2006
  • September 2005
  • June 2005
  • May 2005
  • December 2004
April 2025
S M T W T F S
 12345
6789101112
13141516171819
20212223242526
27282930  
« Feb    

Breast Cancer

  • Cancer Advocacy

Health Advocacy

  • Women’s Universal Health Initiative

Syndication

  • FDA MedWatch

Tags

Big Pharma Watch Birth Control Breast Cancer Cancer Cancer Research CDC Cervarix Cervical Cancer Children's Health Exploitive Behavior FDA FDA Approvals FDA Clinical Trials FDA Failure To Protect FDA Press Release Follow The Money Gardasil Gardasil Adverse Event Gardasil® GlaxoSmithKline GlaxoSmithKline Cervarix Gynecology H1N1 "swine flu" virus H1N1 pandemic influenza preparedness efforts Health Advisory HPV HPV-Associated Cervical Cancer HPV-Vaccination HPV Infection HPV Vaccine HRT Human Papillomavirus (HPV) Infection Merck PAP SMEAR PAP Test Proactive Nutrition Questionable Medicine STD Infection STD Vaccination swine flu vaccine Swine flu vaccine production Take Action! Uncategorized Woman’s Health Your Body/Your Self

Copyright © 2010-2025 Hands On WordPress · All Rights Reserved